GeoWealth Management’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
– Sell
-1,536
Closed -$120K – 903
2025
Q2
$120K Buy
1,536
+97
+7% +$7.23K ﹤0.01% 774
2025
Q1
$104K Sell
1,439
-458
-24% -$32.8K ﹤0.01% 776
2024
Q4
$140K Buy
1,897
+751
+66% +$52.6K ﹤0.01% 878
2024
Q3
$75.6K Buy
+1,146
New +$83.3K ﹤0.01% 957

Other funds holding EW

GeoWealth Management's EW Position: Q3 2025 in Review

GeoWealth Management sold out of Edwards Lifesciences (EW) in Q3 2025, closing a stake of 1,536 shares — an estimated $120K sold.

GeoWealth Management first reported a position in EW in Q3 2024 and held it in 4 quarters. The position peaked at $140K in Q4 2024. 1,255 funds tracked by Wall St. Rank hold EW as of Q3 2025.

  • GeoWealth Management reported no remaining Edwards Lifesciences position as of Q3 2025 after selling out during the quarter.
  • GeoWealth Management sold 1,536 Edwards Lifesciences shares in Q3 2025, an estimated $120K.
  • GeoWealth Management first reported a position in Edwards Lifesciences in Q3 2024 and held it in 4 quarters.
  • GeoWealth Management's Edwards Lifesciences position peaked at $140K in Q4 2024.
  • 1,255 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q3 2025.

Based on GeoWealth Management's 13F filing for Q3 2025, filed 13 Nov 2025.